SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) shares were down 1.2% during mid-day trading on Thursday . The company traded as low as $24.38 and last traded at $24.38. Approximately 200 shares were traded during trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Price Performance
The stock has a market capitalization of $6.64 billion, a P/E ratio of 48.76, a PEG ratio of 1.30 and a beta of 1.81. The stock’s fifty day moving average price is $24.38 and its 200 day moving average price is $24.38.
SWEDISH ORPHAN/S Company Profile
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
Featured Articles
- Five stocks we like better than SWEDISH ORPHAN/S
- The Role Economic Reports Play in a Successful Investment Strategy
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- What is MarketRank™? How to Use it
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
